Authors:
Goodkin, DE
Shulman, M
Winkelhake, MJ
Waubant, E
Andersson, PB
Stewart, T
Nelson, S
Fischbein, N
Coyle, PK
Frohman, E
Jacobs, L
Holcenberg, J
Lee, M
Mocci, S
Citation: De. Goodkin et al., A phase I trial of solubilized DR2 : MBp(84-102) (AG284) in multiple sclerosis, NEUROLOGY, 54(7), 2000, pp. 1414-1420